Anat Gershoni - Concepedia

Author

Anat Gershoni

Also Known As

A. Gershoni, Anat Gershoni

Publications

622

Citations

H-Index

Concepts

All Affiliations

Anat Gershoni is an author at Weizmann Institute of Science specializing in cancer research, medicine, and tumor biology.

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	552
2	Cell Biology	4	4	262
3	Molecular Biology	2	2	315
4	Pathology	2	2	204
5	Engineering	1	1	97

Anat Gershoni

Publications

552

Citations

H-Index

Page 1

	Year	Citations
A Systematic p53 Mutation Library Links Differential Functional Impact to Cancer Mutation Pattern and Evolutionary Conservation Eran Kotler, Odem Shani, Guy Goldfeld, Molecular Cell Functional GenomicsCancer Mutation PatternSomatic VariantTumor HeterogeneityGenetics	2018	290
The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulation Yael Aylon, Anat Gershoni, Ron Rotkopf, Genes & Development Cancer ResearchHippo PathwaySignaling PathwayOxysterolMedicine	2016	107
Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patients Ori Hassin, Nishanth Belugali Nataraj, Michal Shreberk‐Shaked, Nature Communications EngineeringPathologyCancer BiologyTumor BiologyTranscriptional Regulation	2022	97
LATS1 and LATS2 suppress breast cancer progression by maintaining cell identity and metabolic state Noa Furth, Ioannis S. Pateras, Ron Rotkopf, Life Science Alliance Breast OncologyCancer BiologyMammary Gland DevelopmentTumor BiologyCell Regulation	2018	33
Cross-talk between mutant p53 and p62/SQSTM1 augments cancer cell migration by promoting the degradation of cell adhesion proteins Saptaparna Mukherjee, Martino Maddalena, YiQing Lü, Proceedings of the National Academy of Sciences Cell AdhesionMolecular BiologyCancer BiologyTumor BiologyMutant P53	2022	25

Page 1